Skip to main content
Premium Trial:

Request an Annual Quote

23andMe: Wade Walke

Wade Walke has joined 23andMe as VP of investor relations. Previously, he held the same title at Ionis Pharmaceuticals, and before that, he held various positions at Lexicon Pharmaceuticals, including associate director of bioinformatics in the department of functional genomics and head of communications and investor relations. Walke holds a BSc from Brigham Young University as well as PhD and MSc degrees from the University of Michigan.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.